Niagen Bioscience Inc ( NAGE) - Stock Earnings
NAGE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 4.1 million USD | 33.8 million USD |
| 2026Q1 | 6.3 million USD | 31.5 million USD |
| 2026Q2 | 963000 USD | 29.8 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
NAGE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -4.9 million USD | 83.6 million USD |
| 2024 | 8.6 million USD | 99.6 million USD |
| 2025 | 17.4 million USD | 129.4 million USD |
| 2026 Est. | — | — |
NAGE
Price: $3.18
52 week price:
Earnings Per Share: 0.19 USD
P/E Ratio: 16.05
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 242.9 million